In vivo metabolism of alpha-tocopherol in lipoproteins and liver
studies on rabbits in response to acute cholesterol loading
Keywords:
Atherosclerosis, Alpha-tocopherol, HDLAbstract
OBJECTIVE: To investigate the transport of alpha-tocopherol in lipoproteins of rabbits under normal diet and under acute loading of cholesterol. DESIGN: Two New Zealand White rabbits were fed 14C-alpha-tocopherol acetate in a single oral dose and the recovery of radiolabel in lipoproteins and plasma was monitored. Low density lipoprotein (LDL) from these animals was obtained and labeled with [3H] cholesteryl ester. Three other rabbits were injected with this double-labeled LDL in the native form; while three other animals received this LDL in the acetylated form. RESULTS: Plasma clearance, liver uptake and levels of radiolabel in high density lipoprotein (HDL) of animals injected with 14C[3H]acetyl LDL were significantly higher than those in animals injected with 14C[3H]native LDL. Larger particles of HDL, rich in apolipoprotein E (apoE) carried significantly higher levels of both labels in rabbits injected with acetylated LDL. CONCLUSION: These results provide evidence for in vivo mechanisms of "reverse alpha-tocopherol transport", analogous to "reverse cholesterol transport".
Downloads
References
Miller NE. Raising high density lipoprotein. The clinical implications of recent studies. Biochem Pharmacol 1990;40:403-10.
Glomset JA. The plasma lecithin: cholesterol acyltransferase reactions. J Lipid Res 1968;9:155-67.
Barter PJ. High density lipoprotein and reverse cholesterol transport. Curr Opin Lipidol 1993;4:210-7.
Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoprotein and coronary atherosclerosis. Arterioscl Thromb 1991;11:174-82.
Wilson HM, Patel JC, Russell D, Skinner ER. Alterations in the concentration of an apolipoprotein-E containing subfraction of high density lipoprotein in coronary heart disease. Clin Chim Acta 1993;220:175-87.
Kayden HJ, Traber MG. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 1993;34:343-58.
Parthasarathy S, Rankin SM. Role of oxidised low density lipoprotein in atherogensesis. Prog Lipid Res 1992;31:127-43.
Carpenter KL, van-den-Veer C, Taylor SE, Hardwick SJ, Clare K, Hegyi L, Mitchinson MJ. Macrophages, lipid oxidation, ceroid accumulation and alpha-tocoperol depletion in human atherosclerotic lesions. Gerontology 1995;41:53-67.
Ozer NK, Boscoboinik D, Azzi A. New roles of high density lipoprotein and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int 1995;35:117-24.
Sun J, Giraud DW, Moxley KA, Driskell JA. Beta-carotene and alpha-tocopherol inhibit the development of atherosclerotic lesions in hypercholesterolemic rabbits. Int J Vitamin Nutr Res 1997;67:155-63.
Salonen R, Seppanen K, Rauramaa R, Sepanen JT. Prevalence of carotid atheorsclerosis and serum cholesterol levels in eastern Finland. Atherosclerosis 1988;70:155-60.
Riemersma RA, Oliver M, Elton RA, Afthan G, Vartiainen E, Salo M, Rubba P, Mancini M, Georgi H, Vuilleumier JP, Gey KF. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur J Clin Nutr 1990;44:143-50.
Gey FK, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-34S.
Riemersma RA, Wood DA, MacIntyre CCA, Elton RA, Gey KF, Oliver MF. Antioxidants and pro-oxidants in coronary heart disease. Lancet 1991;337:432-3.
Hense HW, Stender M, Bors W, Keil U. Lack of association between serum vitamin E and miocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993;103:21-8.
Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infraction: are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-6.
Ohrvall M, Berglund L, Salminen I, Lithell H, Aro A, Vessby B. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha-tocopherol predicts the development of myocardial infarction in 50 year old men. Atherosclerosis 1996;127:65-71.
Brown AJ, Fragoso YD. Alpha-tocopherols and carotenes are differently distributed in subfractions of high density lipoprotein. Biochim Biophys Acta 1994;1210:373-6.
Skinner ER. High density lipoprotein subspecies. Curr Opin Lipidol 1994;5:241-7.
Chapman JM. Animal lipoproteins: chemistry, structure and comparative aspects. J Lipid Res 1980;21:789-853.
Fragoso YD, Skinner ER. The role of subfractions of high density lipoprotein in the in vivo transport of cholesterol from cholesterol loaded hepatic and peripheral endothelial cells in the New Zealand White rabbit. Comp Biochem Physiol 1993;105B:699-706.
Fragoso YD, Skinner ER. Cholesterol loading of peripheral tissues alters the interconversion of high density lipoprotein subfractions in rabbits. Int J Cell Biol 1996;28:151-63.
Fragoso YD, Skinner ER. The effect of gammalinolenic acid on the subfractions of high density lipoprotein of the rabbit. Biochem Pharmacol 1992;44:1085-90.
Hay C, Rooke JA, Skinner ER. Fractionation of rat HDL by affinity chromatography: effect of prolonged ultracentrifugation on HDL subspecies. FEBS Lett 1978;91:30-3.
Weisgraber KH, Mahley RW. Subfractionation of human high density lipoprotein by heparin-Sepharose affinity chromatography. J Lipid Res 1980;21:316-25.
Griffin BA, Skinner ER, Maughan RJ. Plasma high density lipoprotein subfractions in subjects with different coronary risk indices as assessed by plasma protein concentrations. Atherosclerosis 1988;70:165-9.
Basu SK, Goldstein JL, Anderson RGW, Brown, MS. Degradation of cathionised low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia. Proc Natl Acad Sci (USA) 1976;73:3178-82.
Klimov AN, Kozhemyakin LA, Pleskov VM, Andreeva LI. Antioxidant effect of high density lipoprotein in the peroxidation of low density lipoprotein. Byull Eksp Biol Med 1987;103:550-2.
Mackness MI, Arrol A, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein. FEBS Lett 1991;286: 152-4.
Mackness MI, Abbot C, Arrol A, Durrington PN. The role of high density lipoprotein and lipid soluble antioxidant vitamin in inhibiting low density lipoprotein oxidation. Biochem J 1993;294:829-34.
Gocke N, Frei B. Basic research in antioxidant inhibition of steps in atherosclerosis. J Cardiovasc Risk 1996;3:352-7.
Maseri A. Inflammation, atherosclerosis and ischemic event - exploring the hidden side of the moon. N Engl J Med 1997;336:1014-6.
Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.
Traber MG, Ramakrishnan R, Kayden HJ. Human plasma vitamin E kinetics demonstrates rapid recycling of plasma RRR-alpha-tocopherol. Proc Natl Acad Sci USA 1994;91:10005-8.
Nagelkerke JF, Barto KP, Van Berkel TJ. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchimal cells. J Biol Chem 1983; 258:12221-7.
Blomhoff R, Drevon CA, Eskild W, Helgerud P, Norum KR, Berg T. Clearance of acetyl low density lipoprotein by rat endothelial cells. J Biol Chem 1984;259:8898-903.
Van Berkel TJC, De Rijke YB, Kruijt JK. Saturable high affinity binding, uptake and degradation of rat plasma lipoproteins by isolated parenchymal and non-parenchymal cells from rat liver. J Biol Chem 1981;226:2282-9.
Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidised lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 1995;15:1616-24.
Olsson AG, Yuan XM. Antioxidants in the prevention of atherosclerosis. Curr Opin Lipidol 1996;7:374-80.
